Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib

A series of novel sorafenib analogues containing a quinoxalinedione ring and amide linker were synthesized. A total of 9 novel compounds in 6 synthetic steps were synthesized. Briefly, the amino group of p-aminophenol was first protected which then followed by O-arylation with 5-chloro-2-nitroanilin...

Full description

Bibliographic Details
Main Authors: Mojtaba Khandan, Sedighe Sadeghian Rizi, Ghadamali Khodarahmi, Farshid Hassanzadeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Research in Pharmaceutical Sciences
Subjects:
Online Access:http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2018;volume=13;issue=2;spage=168;epage=176;aulast=Khandan
_version_ 1830132152535089152
author Mojtaba Khandan
Sedighe Sadeghian Rizi
Ghadamali Khodarahmi
Farshid Hassanzadeh
author_facet Mojtaba Khandan
Sedighe Sadeghian Rizi
Ghadamali Khodarahmi
Farshid Hassanzadeh
author_sort Mojtaba Khandan
collection DOAJ
description A series of novel sorafenib analogues containing a quinoxalinedione ring and amide linker were synthesized. A total of 9 novel compounds in 6 synthetic steps were synthesized. Briefly, the amino group of p-aminophenol was first protected which then followed by O-arylation with 5-chloro-2-nitroaniline to provide compound d. Reduction of the nitro group of compound d and cyclization of the diamine group of compound e with oxalic acid afforded compound f which on deacetylation yeilded compound g. Then compound g was reacted with different acyl halides to afford the target compounds 1h-1p. Chemical structures of synthesized compounds were confirmed by 1H NMR and FT-IR analysis. All compounds were evaluated at 1, 10, 50 and 100 μM concentrations for their cytotoxicity against HeLa and MCF-7 cancer cell lines. Some of the compounds showed good cytotoxic activity, especially compounds 1i and 1k-1n with the IC50 values of 19, 16, 22, 18, and 16 μM against MCF-7 cell line and 20, 18, 25, 20, and 18 μM against HeLa cell line, respectively.
first_indexed 2024-12-17T06:29:11Z
format Article
id doaj.art-4a93a176926c4954a7c016431af6c542
institution Directory Open Access Journal
issn 1735-5362
1735-9414
language English
last_indexed 2024-12-17T06:29:11Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Research in Pharmaceutical Sciences
spelling doaj.art-4a93a176926c4954a7c016431af6c5422022-12-21T22:00:11ZengWolters Kluwer Medknow PublicationsResearch in Pharmaceutical Sciences1735-53621735-94142018-01-0113216817610.4103/1735-5362.223802Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenibMojtaba KhandanSedighe Sadeghian RiziGhadamali KhodarahmiFarshid HassanzadehA series of novel sorafenib analogues containing a quinoxalinedione ring and amide linker were synthesized. A total of 9 novel compounds in 6 synthetic steps were synthesized. Briefly, the amino group of p-aminophenol was first protected which then followed by O-arylation with 5-chloro-2-nitroaniline to provide compound d. Reduction of the nitro group of compound d and cyclization of the diamine group of compound e with oxalic acid afforded compound f which on deacetylation yeilded compound g. Then compound g was reacted with different acyl halides to afford the target compounds 1h-1p. Chemical structures of synthesized compounds were confirmed by 1H NMR and FT-IR analysis. All compounds were evaluated at 1, 10, 50 and 100 μM concentrations for their cytotoxicity against HeLa and MCF-7 cancer cell lines. Some of the compounds showed good cytotoxic activity, especially compounds 1i and 1k-1n with the IC50 values of 19, 16, 22, 18, and 16 μM against MCF-7 cell line and 20, 18, 25, 20, and 18 μM against HeLa cell line, respectively.http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2018;volume=13;issue=2;spage=168;epage=176;aulast=Khandancytotoxicity; sorafenib; quinoxalinedione; amide
spellingShingle Mojtaba Khandan
Sedighe Sadeghian Rizi
Ghadamali Khodarahmi
Farshid Hassanzadeh
Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib
Research in Pharmaceutical Sciences
cytotoxicity; sorafenib; quinoxalinedione; amide
title Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib
title_full Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib
title_fullStr Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib
title_full_unstemmed Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib
title_short Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib
title_sort synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib
topic cytotoxicity; sorafenib; quinoxalinedione; amide
url http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2018;volume=13;issue=2;spage=168;epage=176;aulast=Khandan
work_keys_str_mv AT mojtabakhandan synthesisandcytotoxicevaluationofsomenoveldiarylamidepossessingquinoxalinedionebasedonsorafenib
AT sedighesadeghianrizi synthesisandcytotoxicevaluationofsomenoveldiarylamidepossessingquinoxalinedionebasedonsorafenib
AT ghadamalikhodarahmi synthesisandcytotoxicevaluationofsomenoveldiarylamidepossessingquinoxalinedionebasedonsorafenib
AT farshidhassanzadeh synthesisandcytotoxicevaluationofsomenoveldiarylamidepossessingquinoxalinedionebasedonsorafenib